The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective

Show simple item record Ansari, Shamshul Hays, John P. Kemp, Andrew Okechukwu, Raymond Murugaiyan, Jayaseelan Ekwanzala, Mutshiene Deogratias Ruiz Alvare, Maria Josefina Paul-Satyaseela, Maneesh Iwu, Chidozie Declan Balleste-Delpierre, Clara Septimus, Ed Mugisha, Lawrence Fadare, Joseph Chaudhuri, Susmita Chibabhai, Vindana Wadanamby, J.M. Rohini W.W. Daoud, Ziad Xiao, Yonghong Parkunan, Thulasiraman Khalaf, Yara Van Dongen, Maarten B. M. Barkema, Herman W. Strathdee, Steffanie Benyeogor, Emmanuel Ighodalo, Uzairue Leonard Prasad, Kurcheti Pani M., Carlos Gu, Yoshiaki Essack, Sabiha De Silva, Dilan Vellinga, Akke Ghannam, Wagih Mommtaz Tsoho, Najib Auwal Sakeena, M.H.F. Ilenwabor, Rhoda Shetty, Dhanuraj (Raj) Ayebare, Arnold Traore, Zoumana Isaa Henry, Ola Kiran, Amritanjali Ilenwabor, Rhoda Toro, Luisa Fernanda Smail, Adil Amulele, Anne Founou, Luria Leslie Sawant, Prathamesh S. Buregyeya, Esther Castro-Sanchez, Enrique Moreno-Morales, Javier Izadjoo, Mina Gori, Andrea Goff, Debra Blocker, Arielle Forte, Giovanna Tahir, Muhammad Farooq Diggle, Mathew Chakraborty, Dipanjan Asamoah, Anita E. Humphrey Aberi 2022-08-30T11:35:03Z 2022-08-30T11:35:03Z 2021-06
dc.description.abstract The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR. en_US
dc.description.department School of Health Systems and Public Health (SHSPH) en_US
dc.description.librarian am2022 en_US
dc.description.sponsorship This study was supported by internal funding. en_US
dc.description.uri en_US
dc.identifier.citation Ansari, S., Hays, J.P., Kemp, A. et al. 2021, 'The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective', JAC-Antimicrobial Resistance, vol. 3, no. 3, pp. 1-12, doi : 10.1093/jacamr/dlab038. en_US
dc.identifier.issn 2632-1823
dc.identifier.other 10.1093/jacamr/dlab038
dc.language.iso fr en_US
dc.publisher Oxford University Press en_US
dc.rights © The Author(s) 2021. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License. en_US
dc.subject Impact en_US
dc.subject Challenge en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) en_US
dc.subject Antimicrobial resistance (AMR) en_US
dc.subject Biocide resistance en_US
dc.title The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record